The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Drugs Used to Treat Spasticity
Abstract
Spasticity is a common and disabling symptom for many patients with upper motor neuron dysfunction. It results from interruption of inhibitory descending spinal motor pathways, and although the pathophysiology of spasticity is poorly understood, the final common pathway is overactivity of the alpha motor neuron. Therapy for spasticity is symptomatic with the aim of increasing functional capacity and relieving discomfort. Any approach to treatment should be multidisciplinary, including physical therapy, and possibly surgery, as well as pharmacotherapy. It is important that treatment be tailored to the individual patient, and that both patient and care giver have realistic expectations. Pharmacotherapy is generally initiated at low dosages and then gradually increased in an attempt to avoid adverse effects. Optimal therapy is the lowest effective dosage. Baclofen, diazepam, tizanidine and dantrolene are currently approved for use in patients with spasticity. In addition, clonidine (usually as combination therapy), gabapentin and botulinum toxin have shown efficacy, however, more studies are required to confirm their place in therapy. Intrathecal baclofen, via a surgically implanted pump and reservoir, may provide relief in patients with refractory severe spasticity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term BZD use may also be appropriate for medical conditions such as complex seizure disorders,42 spasticity,43,44 sleep disorders involving abnormal movements (e.g., rapid eye movement (REM) sleep behavior disorder, restless leg syndrome),45 and catatonia.46,47”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [42]
Citations
Cites
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
Ashworth, B. (1964) · PubMed · Cited by 1,475
Spasticity, disordered motor control
Feldman, R. G., Young, R. R., & Koella, W. P. (1980) · Medical Entomology and Zoology · Cited by 1,121
Intrathecal Baclofen for Severe Spinal Spasticity
Penn, R. D., Savoy, S. M., Corcos, D., Latash, M., Gottlieb, G., Parke, B., & Kroin, J. S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202303 · Cited by 754
Electrophysiology of GABAA and GABAB receptor subtypes
Bormann, J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90156-7 · Cited by 641
Molecular Mechanisms in the Receptor Action of Benzodiazepines
Costa, E., & Guidotti, A. (1979) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.19.040179.002531 · Cited by 587
Simpson, D. M., Alexander, D. N., O'Brien, C. F., Tagliati, M., Aswad, A. S., Leon, J. M., Gibson, J., Mordaunt, J. M., & Monaghan, E. P. (1996) · Neurology · doi:10.1212/wnl.46.5.1306 · Cited by 418
Treatment of spasticity with botulinum toxin: A double‐blind study
Snow, B. J., Tsui, J. K. C., Bhatt, M. H., Varelas, M., Hashimoto, S. A., & Calne, D. B. (1990) · Annals of Neurology · doi:10.1002/ana.410280407 · Cited by 414
BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY
Cosgrove, A. P., Corry, I. S., & Graham, H. K. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11864.x · Cited by 354
Antispasticity drugs: Mechanisms of action
Davidoff, R. A. (1985) · Annals of Neurology · doi:10.1002/ana.410170202 · Cited by 340
Koman, L. A., Mooney, J. F., Smith, B. P., Goodman, A., & Mulvaney, T. (1994) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-199405000-00005 · Cited by 304
Research works printed but not linked: 23
- Jerusalem, 1968, Nervenarzt, 39, 515
- Basmajan, 1975, Am J Phys Med, 54, 175
- Duncan, 1976, Neurology, 441, 446
- Levine, 1977, Dis Nerv Sys, 38, 1011
- Pedersen, 1974, Arch Phys Med Rehabil, 55, 344
- Kendall, 1964, Ann Phys Med, 7, 225
- Corbett, 1972, Paraplegia, 10, 19
- Roussan, 1987, Pharmatherapeutica, 4, 278
- Coward, 1981, Triangle, 20, 151
- Newman, 1982, Clin Pharmacol, 23, 31
- Bass, 1988, Can J Sci, 15, 15
- Smolenski, 1981, Curr Med Res Opin, 7, 374
- Pagano, 1988, Rev Neurol Argent, 14, 268
- Nance, 1989, Paraplegia, 4, 296
- Dall, 1996, Brain Injury, 10, 453
- Herman, 1972, Am J Physical Med, 51, 296
- Ellis, 1974, Arch Phys Med Rehabil, 55, 362
- Monster, 1979, Acta Neurol Scand, 59, 309
- Katrak, 1992, Arch Phys Med Rehabil, 73, 4
- Nogen, 1976, Childs Brain, 2, 304
- Glass, 1974, Paraplegia, 12, 170
- Ashworth, 1964, Practitioner, 192, 540
- Lee, 1989, J Neuro Rehab, 3, 205
Cited by
Sinclair, M. D. (2003) · PubMed · Cited by 726
Spasticity after spinal cord injury
Adams, M. M., & Hicks, A. L. (2005) · Spinal Cord · doi:10.1038/sj.sc.3101757 · Cited by 517
The spinal pathophysiology of spasticity – from a basic science point of view
Nielsen, J. B., Crone, C., & Hultborn, H. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01652.x · Cited by 431
Chou, R., Peterson, K., & Helfand, M. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.05.002 · Cited by 375
Cerebral palsy, new therapeutic possibilities
Rotta, N. T. (2002) · Jornal de Pediatria · doi:10.1590/s0021-75572002000700008 · Cited by 225
Metadata
- Authors
- Kita, M., & Goodkin, D. E.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Kita, Mariko
- Venue
- Drugs
- Published
- 2000-03
- Volume
- 59
- Issue
- 3
- Pages
- 487-495
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W2164949224
- Cited by
- 172
- References
- 78
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 8 · 2020: 4 · 2019: 5 · 2018: 9 · 2017: 2 · 2016: 10 · 2015: 9 · 2014: 7 · 2013: 7 · 2012: 9
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Health Sciences › Medicine › Rehabilitation › Cerebral Palsy and Movement Disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- spasticity, baclofen, diazepam, tizanidine, dantrolene, clonidine, gabapentin, botulinum toxin, intrathecal baclofen, upper motor neuron dysfunction, multidisciplinary management
- MeSH terms
- Baclofen, Clonidine, Dantrolene, Diazepam, Drug Administration Schedule, Humans, Muscle Relaxants, Central, Muscle Spasticity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drugs Used to Treat Spasticity. https://app.cochat.ai/papers/10.2165/00003495-200059030-00006
- The paper
- Kita, M., & Goodkin, D. E. (2000). Drugs Used to Treat Spasticity. Drugs. https://doi.org/10.2165/00003495-200059030-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.